|
CommitDrug - Commit The trade name of the product as shown on the labeling.
Dosage -
TROCHE/LOZENGE; ORAL
Active Ingredient(s) -
Nicotine Polacrilex
Strength -
EQ 2MG BASE
Applicant -
GLAXOSMITHKLINE CONS
New Drug Application (NDA) Number -
021330
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Oct 31, 2002
Reference Listed Drug (RLD) -
No
Type -
OTC
Applicant Full Name -
Glaxosmithkline Consumer Healthcare
Commit
Nicotine Polacrilex (mint) Eq 4mg Base Gum, Chewing; Buccal
Nicotine Polacrilex (orange) Eq 2mg Base Gum, Chewing; Buccal Nicotine Polacrilex (orange) Eq 4mg Base Gum, Chewing; Buccal Commit Eq 2mg Base Troche/lozenge; Oral Nicotine Polacrilex Eq 2mg Base Gum, Chewing; Buccal Nicotine Polacrilex Eq 4mg Base Gum, Chewing; Buccal Nicotine Polacrilex Eq 4mg Base Gum, Chewing; Buccal Nicotine Polacrilex (mint) Eq 2mg Base Gum, Chewing; Buccal Nicotine Polacrilex (mint) Eq 4mg Base Gum, Chewing; Buccal Nicotine Polacrilex (mint) Eq 2mg Base Gum, Chewing; Buccal NewDrugInformation |